Esso Societe Anonyme Francaise SA (0N9V)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 75.90 |
|---|---|
| 52-week range | 37.86 – 112.10 |
| Return, 1 month / 3 months | −25.5% / +18.5% |
| Return, 1 year / 3 years | −17.6% / +35.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 35 |
| Volatility (1 year) | 100.3% |
| Worst drawdown (1 year) | -63.6% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Esso Société Anonyme Française is the French arm of ExxonMobil, based in France. It refines crude oil and supplies petroleum products, including motor fuels, heating oil and lubricants, to motorists through Esso service stations and to industrial, commercial and agricultural customers. The company also provides related services such as fuel cards and logistics for business fleets, and it serves both retail and wholesale markets across the country.
On this site Esso Societe Anonyme Francaise SA appears as a stock on the London Exchange (UK), code 0N9V, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Esso Societe Anonyme Francaise SA (0N9V) trades on the London Exchange in UK. It last closed at EUR 75.90 on 19 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 2,402 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 17.6% and over the last three months it rose 18.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 23.3% | ||
| From 52-week high | -31.3% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 18.5% | ||
| 6-month return | 47.0% | ||
| 12-month return, skipping the last month | 10.6% | ||
| Stability (higher is calmer) | 8 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 100.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -63.6% | ||
| Liquidity | 19 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 9 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −7.6% |
|---|---|
| 1 month | −25.5% |
| 3 months | +18.5% |
| 6 months | +47.0% |
| 1 year | −17.6% |
| 3 years | +35.4% |
| 5 years | +619.1% |
Signals
| 50-day / 200-day average | 86.23 / 61.54 |
|---|---|
| Golden / death cross (60 days) | Golden, 50 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.09 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Nov 2025 | EUR 0.6021 |
| 8 Jul 2025 | EUR 3.0000 |
| 8 Jul 2024 | EUR 3.0000 |
| 10 Jul 2023 | EUR 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.